Marni Hall is Vice President of Clinical Evidence in the Center of Advanced Evidence Generation at IQVIA, where she reports to the Chief Scientific Officer in our Real-World and Analytic Solutions Division. In this role Hall is leveraging her expertise in regulatory science, drug safety, and patient-centricity, providing scientific oversight and strategic direction on the expanded use of real world evidence for regulatory and other uses.
A research scientist by training, Dr. Hall spent nearly two decades at the intersection of science and policy. She started her career studying biochemistry, toxicology and molecular epidemiology at Columbia University. After serving as Program Director in the Public Health Group of External Medical Affairs at Pfizer, Hall joined the FDA’s Office of Planning and Informatics in 2008 as a Principal Analyst. In this role, she initiated and led the development of the data standards plan for the Center for Drug Evaluation and Research (CDER). In 2011, she was appointed Director of Regulatory Science within the Office of Surveillance and Epidemiology (OSE) for the CDER. Hall became an expert at sourcing and analyzing big data sets, including adverse event reports, claims, and other data useful to risk assessment and risk management activities. Then, at PatientsLikeMe, Dr. Hall served as the Senior Vice President of Research and Development, Informatics, and Policy, where she oversaw delivery of commercial research programs and execution of an agenda for use of patient-generated health data in clinical and regulatory decision making.
Hall holds bachelor of science degrees in chemistry and in society, technology, and policy from Worcester Polytechnic Institute. She also holds a master’s degree in public health from Columbia University’s Mailman School of Public Health as well as a master of science degree in biochemistry and a PhD in toxicology from Columbia University’s Graduate School of Arts and Sciences.